Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
About Tender
💉 Urgent Procurement Notice For Insulin Aspart And Insulin Protamine 💉 The Department Of Defence Production, Ministry Of Defence, Issues A Procurement Notice For The Supply Of Insulin Aspart (30%) And Insulin Protamine (70%) In A 3m L Vial With A Concentration Of 100 Iu Per Ml, For Human Use. 🗓️ Deadline: July 23, 2024, 5:00 Pm Suppliers Must Provide Evidence Of The Quality And Efficacy Of Their Insulin Products, Along With Competitive Pricing And Reliable Supply Chain Logistics. Keywords: Insulin Aspart, Insulin Protamine, Human Insulin, Procurement, Ministry Of Defence, Department Of Defence Production| Particulars | Details |
|---|---|
| Title |
Insulin Aspart 30 Percent And Insulin Protamine As Part 70 Percent 100 Iu Per Ml 3 Ml,Human Insulin A
|
| Description |
|
| Organisation | Department of Defence Production | Ministry of Defence |
| Tender Id | GEM/2024/B/5075567 |
|
Reference Number |
- |
| Tender Fee | - |
| EMD | - |
| Tender Value | - |
| Place | |
| Link |
View Original Tender Notice
https://bidplus.gem.gov.in/all-bids |
| Start Date | July 02, 2024 22:14 |
| End Date |
Expired
23/07/2024
Expired 815 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Award of Contract & Bid Results
Technical Evaluation Results
| S.No. | Seller Name | Offered Item | Participated On | MSE/MII Status | Status |
|---|---|---|---|---|---|
| 1 | ADIVIS PHARMA PRIVATE LIMITED | - | 29-07-2024 16:15:15 | MSE | Evaluated |
| 2 | EDISON DRUG HOUSE | - | 21-07-2024 21:42:13 | N/A | Evaluated |
| 3 | GULAB MEDICOSE | - | 30-07-2024 14:59:36 | MSE | Evaluated |
| 4 | HALE N HEALTHY MEDICARE PRIVATE LIMITED | - | 30-07-2024 01:27:13 | MSE | Evaluated |
| 5 | JAI GANESH PHARMACEUTICALS | - | 29-07-2024 15:55:14 | N/A | Evaluated |
| 6 | M/S J.R.BIOTECH | - | 30-07-2024 13:56:42 | MSE | Evaluated |
| 7 | M/S R.R.ENTERPRISES | - | 23-07-2024 12:51:38 | MSE | Evaluated |
| 8 | M/S. JAIN MEDICAL STORE | - | 23-07-2024 09:34:42 | N/A | Evaluated |
| 9 | M/S. MAA AMBIKA PHARMACEUTICALS | - | 23-07-2024 11:02:04 | MSE | Evaluated |
| 10 | M/S.JAI SIVA AGENCIES | - | 22-07-2024 17:40:43 | MSE | Evaluated |
| 11 | MODAK MEDICINE HOUSE | - | 30-07-2024 14:55:25 | MSE | Evaluated |
| 12 | OM MEDICAL STORE | - | 23-07-2024 16:59:29 | MSE | Evaluated |
| 13 | REGALE PHARMA | - | 23-07-2024 16:58:14 | MSE | Evaluated |
| 14 | REKIN PHARMA PRIVATE LIMITED | - | 28-07-2024 10:37:47 | MSE | Evaluated |
| 15 | SHINE PHARMACEUTICALS LIMITED | - | 23-07-2024 10:27:19 | N/A | Evaluated |
| 16 | sk life sciences | - | 23-07-2024 15:47:01 | MSE | Evaluated |
| 17 | SUNESTA LIFE SCIENCES | - | 23-07-2024 11:45:19 | MSE | Evaluated |
Inj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge
Inj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge
Read moreCartr insulin - human regular insulin r dna origin 100iu/ml -3ml
Cartr insulin - human regular insulin r dna origin 100iu/ml -3ml
Read moreBiphasic isophane insulin 30/70 injection (100iu/ml) , (r-dna origin) , 3ml cartridge,multivitamin
Biphasic isophane insulin 30/70 injection (100iu/ml) , (r-dna origin) , 3ml cartridge,multivitamin
Read moreInj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.
Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.
Read moreInsulin degludec (r-dna origin)100iu/ml in 3ml penfills
Insulin degludec (r-dna origin)100iu/ml in 3ml penfills
Read moreInj insulin - human mixtard 70/30 100 iu/10 ml
Inj insulin - human mixtard 70/30 100 iu/10 ml
Read moreHq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml
Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml
Read moreInsulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen
Insulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen
Read more(ph no.:10013) human insulin mix.of 30/70 (rdna origin) 40 iu/ml - 10 ml inj.
(ph no.:10013) human insulin mix.of 30/70 (rdna origin) 40 iu/ml - 10 ml inj.
Read moreBiphasic isophane insulin injection 50 percent soluble & 50 percent isophane of 100iu per ml of 10ml vial
Biphasic isophane insulin injection 50 percent soluble & 50 percent isophane of 100iu per ml of 10ml vial
Read moreof your Industry type